LINC02205: A Long Intergenic Non-Protein Coding RNA as a Potential Drug Target and Biomarker

Target Name: LINC02205

NCBI ID: G105370880

LINC02205

Other Name(s): long intergenic non-protein coding RNA 2205 | Long intergenic non-protein coding RNA 2205

LINC02205: A Long Intergenic Non-Protein Coding RNA as a Potential Drug Target and Biomarker

LINC02205 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells, including brain, heart, and liver. LINC02205 has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation.

One of the key features of LINC02205 is its length. It is approximately 220 base pairs long, which makes it one of the longest lncRNA molecules that has been identified. This length allows for a large range of potential interactions with other molecules in the cell.

In addition to its length, LINC02205 has several other features that make it an attractive drug target. For example, it is highly expressed in brain and heart tissue, which suggests that it may be involved in the regulation of neural and cardiovascular processes. Additionally, LINC02205 has been shown to play a role in the regulation of cellular apoptosis, which is a process that is involved in cell death. This suggests that it may be a potential drug target for diseases that are characterized by excessive cell death, such as cancer.

Another potential mechanism by which LINC02205 may be involved in disease is its role in the regulation of inflammation. LINC02205 has been shown to be involved in the regulation of the cytokine signaling pathway, which is a critical pathway that is involved in the regulation of immune responses and inflammation. This suggests that LINC02205 may be a potential drug target for diseases that are characterized by inflammation, such as rheumatoid arthritis or multiple sclerosis.

In addition to its potential role in drug targeting and biomarker development, LINC02205 is also of interest as a potential therapeutic target. Because it is a non-protein coding RNA molecule, it is not subject to the same regulations as proteins, which may make it a more attractive target for small molecules. This allows for the possibility of using LINC02205 as a potential drug or biomarker in a variety of therapeutic contexts.

Overall, LINC02205 is a promising candidate for drug targeting and biomarker development due to its unique properties, including its long length and its potential role in cell growth, apoptosis, inflammation, and other cellular processes. Further research is needed to fully understand the potential of LINC02205 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2205

The "LINC02205 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02205 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets